Role of the transcription factor Fli-1 on the CXCL10/CXCR3 Axis
Xuan Wang1,2, Mara Lennard Richard2, Tomika S Caldwell2
1Department of General Practice, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Abstract:
The transcription factor Fli-1, a member of the ETS family of transcription factors, is implicated in the pathogenesis of lupus disease. Reduced Fli-1 expression in lupus mice leads to decreased renal Cxcl10 mRNA levels and renal infiltrating CXCR3+ T cells that parallels reduced renal inflammatory cell infiltration and renal damage. Inflammatory chemokine CXCL10 is critical for attracting inflammatory cells expressing the chemokine receptor CXCR3. The CXCL10/CXCR3 axis plays a role in the pathogenesis of various inflammatory diseases including lupus. Our data here demonstrate that renal CXCL10 protein levels are significantly lower in Fli-1 heterozygous MRL/lpr mice compared to wild-type MRL/lpr mice. Knockdown of Fli-1 significantly reduced CXCL10 secretion in mouse and human endothelial cells, and human mesangial cells, upon LPS or TNFα stimulation. The Fli-1 inhibitor, Camptothecin, significantly reduced CXCL10 production in human monocyte cells upon interferon stimulation. Four putative Ets binding sites in the Cxcl10 promoter showed significant enrichment for FLI-1; however, FLI-1 did not directly drive transcription from the human or mouse promoters, suggesting FLI-1 may regulate CXCL10 expression indirectly. Our results also suggest that the DNA binding domain of FLI-1 is necessary for regulation of human hCXCR3 promotor activity in human T cells and interactions with co-activators. Together, these results support a role for FLI-1 in modulating the CXCL10-CXCR3 axis by directly or indirectly regulating the expression of both genes to impact lupus disease development. Signaling pathways or drugs that reduce FLI-1 expression may offer novel approaches to lupus treatment.
Insights
Reduced Fli-1 expression impacts lupus by altering CXCL10 and CXCR3 levels, suggesting new therapeutic targets for lupus disease.
Area of Science:
- Immunology
- Molecular Biology
- Rheumatology
Background:
- The transcription factor Fli-1 (Friend Leukemia Integration 1) is involved in lupus pathogenesis.
- Reduced Fli-1 expression correlates with decreased renal CXCL10 and CXCR3+ T cells in lupus models.
- The CXCL10/CXCR3 axis is crucial in inflammatory diseases like lupus.
Purpose of the Study:
- To investigate the role of Fli-1 in regulating the CXCL10/CXCR3 axis in lupus.
- To explore Fli-1's direct or indirect mechanisms in controlling CXCL10 and CXCR3 expression.
Main Methods:
- Analysis of renal CXCL10 protein levels in Fli-1 heterozygous MRL/lpr mice.
- Fli-1 knockdown experiments in endothelial, mesangial, and monocyte cells.
- Assessment of Fli-1 inhibitor (Camptothecin) effects on CXCL10 production.
- ChIP-qPCR and reporter assays to evaluate Fli-1 binding and transcriptional activity on Cxcl10 and Cxcr3 promoters.
Main Results:
- Renal CXCL10 protein levels were significantly lower in Fli-1 heterozygous MRL/lpr mice.
- Fli-1 knockdown reduced CXCL10 secretion in various cell types upon stimulation.
- Camptothecin treatment decreased CXCL10 production in human monocytes.
- Fli-1 binding sites were enriched in the Cxcl10 promoter, but direct transcription was not observed; Fli-1's DNA binding domain was essential for regulating hCXCR3 promoter activity.
Conclusions:
- Fli-1 modulates the CXCL10-CXCR3 axis, impacting lupus development through direct or indirect regulation of both genes.
- Targeting Fli-1 expression or activity may offer novel therapeutic strategies for lupus.
More Related Videos
10:16SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
Published on: January 6, 2017
08:22Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
Published on: May 31, 2020
Related Concept Videos
General Transcription Factors
Transcription Factors
Canonical Wnt Signaling Pathway
Master Transcription Regulators
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
